Lipase inhibitors are molecules that block the activity of lipases, enzymes responsible for the breakdown of lipids into fatty acids and glycerol. By inhibiting these enzymes, lipase inhibitors can disrupt the lipid metabolism of cells. This can be particularly impactful in cancer cells, which often rely on altered metabolic pathways to support rapid growth and proliferation.
